pomalidomide has been researched along with Amyloidosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hajek, R; Jelinek, T; Kufova, Z | 1 |
| Lo, S; Sanchorawala, V; Seldin, DC; Shelton, AC; Sloan, JM; Varga, C | 1 |
| Basset, M; Foli, A; Merlini, G; Milani, P; Palladini, G; Perlini, S; Russo, F | 1 |
| Buadi, F; Detweiler-Short, K; Dingli, D; Dispenzieri, A; Gertz, MA; Hayman, S; Kumar, SK; Kyle, RA; Lacy, MQ; Leung, N; Lust, JA; Rajkumar, SV; Russell, SJ; Zeldenrust, S | 1 |
| Bergsagel, PL; Buadi, F; Dingli, D; Dispenzieri, A; Fonseca, R; Gertz, MA; Hall, R; Hayman, SR; Kumar, SK; Lacy, MQ; LaPlant, B; Laumann, K; Lust, JA; Mikhael, JR; Rajkumar, SV; Reeder, C; Roy, V; Russell, SJ; Stewart, AK; Witzig, TE; Zeldenrust, SR | 1 |
1 review(s) available for pomalidomide and Amyloidosis
| Article | Year |
|---|---|
Immunomodulatory drugs in AL amyloidosis.
Topics: Amyloidosis; Animals; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Salvage Therapy; Thalidomide | 2016 |
3 trial(s) available for pomalidomide and Amyloidosis
| Article | Year |
|---|---|
Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trial.
Topics: Adult; Aged; Amyloidosis; Dexamethasone; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Survival Analysis; Thalidomide; Treatment Outcome | 2016 |
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Bortezomib; Dexamethasone; Disease-Free Survival; Female; Humans; Immunoglobulin Light Chains; Immunologic Factors; Male; Middle Aged; Survival Rate; Thalidomide | 2017 |
Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis.
Topics: Aged; Aged, 80 and over; Amyloidosis; Antineoplastic Agents; Dexamethasone; Disease-Free Survival; Drug Therapy, Combination; Female; Hematologic Tests; Humans; Immunoglobulin Light Chains; Male; Middle Aged; Plasma Cells; Thalidomide | 2012 |
1 other study(ies) available for pomalidomide and Amyloidosis
| Article | Year |
|---|---|
Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs.
Topics: Amyloid; Amyloidosis; Biomarkers; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Drug Therapy, Combination; Heart Failure; Humans; Immunoglobulin Light Chains; Immunologic Factors; Lenalidomide; Melphalan; Natriuretic Peptide, Brain; Patient Dropouts; Peptide Fragments; Stem Cell Transplantation; Thalidomide; Troponin T | 2010 |